Autolus.com

Autolus.com has Server used 139.59.173.252 IP Address with Hostname in United Kingdom. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2011-11-19 (7 years, 272 days) and hosted in London United Kingdom, server ping response time 79 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Autolus keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Autolus
2 Autolus therapeutics
3 Autolus stock
4 Autolus limited
5 Autolus maryland
6 Autolus ltd
7 Autolus news
8 Autolus rockville md
9 Autolus ticker

Hosting Provider

Website: Autolus.com
Hostname: 139.59.173.252
Country:
Region: H9
City: London
Postal Code: EC4N
Latitude: 51.514198303223
Longitude: -0.093099996447563
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   Pool-hoops.com (23 seconds ago)

   Midloscoop.com (1 seconds ago)

   Propack.pro (34 seconds ago)

   Unitedwayillinois.org (16 seconds ago)

   Wiuupi.org (2 seconds ago)

   Aaronpurvis.com (1 seconds ago)

   Bifshteks.com (46 seconds ago)

   Waterticket.com (4 seconds ago)

   Houseboatbookings.com (19 seconds ago)

   Billgattonhonda.com (9 seconds ago)

   Masasandalyekiralamaankara.com (27 seconds ago)

   Luisviaroma.com (5 seconds ago)

   Delmarnational.com (22 seconds ago)

   Freedomhomesinflorida.com (0 seconds ago)

   Instatakipci.com (27 seconds ago)

   Amyandjordan.com (2 seconds ago)

   Senlcy.com (2 seconds ago)

   Autolus.com (0 seconds ago)

   Sherpaxit.com (0 seconds ago)

   Lifeohm.com (16 seconds ago)

Results For Websites Listing

Found 56 Websites with content related to this domain, It is result after search with search engine

Autolus Therapeutics plc - A leader in cutting-edge T-cell

Autolus utilises advanced cell programming and manufacturing technologies and we have established a development-stage pipeline of products for the treatment of haematological malignancies and solid tumours.

https://www.autolus.com/

Autolus - Our portfolio - Syncona

Autolus is a leader in T-cell programming technologies. it is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer cells, break down their defence mechanisms and eliminate these cells, for haematological cancers and solid tumours.

https://www.synconaltd.com/our-portfolio/autolus

Autolus Autolus - Arix Bioscience

www.autolus.com. Arix Representative. Joe Anderson, PhD. Chief Executive Officer. Autolus was founded on advanced cell programing technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014.

https://arixbioscience.com/portfolio/autolus

Autolus Ltd. | LinkedIn

Keep up with Autolus Ltd. See more information about Autolus Ltd., find and apply to jobs that match your skills, and connect with people to advance your career. Autolus is a private

https://www.linkedin.com/company/autolus-ltd-

Investor Relations | Autolus Therapeutics plc

The Investor Relations website contains information about Autolus Therapeutics plc 's business for stockholders, potential investors, and financial analysts.

https://autolus.gcs-web.com/

Autolus Therapeutics plc (AUTL) Company Profile & Facts

See the company profile for Autolus Therapeutics plc (AUTL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

https://finance.yahoo.com/quote/AUTL/profile

SEC Filing | Autolus Therapeutics plc

Other Events . Press Release . On March 26, 2019, Autolus Therapeutics plc (the “Company”) issued a press release announcing its inaugural R&D Day to be held on March 26, 2019 in New York.

https://autolus.gcs-web.com/node/6996/html

Autolus Therapeutics to Report Second Quarter 2019

See headlines for AUTL View Print Version More from GlobeNewswire. Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8

https://www.nasdaq.com/press-release/autolus-therapeutics-to-report-second-quarter-2019-financial-results-and-host-conference-call-on-20190802-00397

Recently Analyzed Sites